| Financial Year |
March 31 2023 |
| Monetary Funds |
370,553,289.17 |
| Held-for-trading Financial Assets |
5,388,901,935.39 |
| Notes Receivable |
-- |
| Accounts Receivable |
742,621,918.83 |
| Advances to Suppliers |
1,884,887.66 |
| Other Receivables |
23,296,713.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
574,389,887.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
60,678,006.38 |
| Total Current Assets |
7,162,326,638.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
144,789,668.74 |
| Investment Properties |
72,690,369.20 |
| Fixed Assetes |
431,229,106.71 |
| Under-construction Projects |
660,000,408.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
272,050,102.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,370,445.13 |
| Deferred Income Tax Assets |
14,847,357.83 |
| Other Non-Current Assets |
2,986,287.32 |
| Sub-Total of Non-Current Assets |
1,618,980,952.31 |
| Total Assets |
8,781,307,590.70 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
42,400.00 |
| Notes Payable |
-- |
| Accounts Payable |
366,702,669.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,706,309.64 |
| Taxes Payable |
5,129,975.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
63,989,282.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,505,730.85 |
| Other Current Liabilities |
891,419.29 |
| Sub-Total of Current Liabilities |
490,984,098.88 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,586,275.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,105,333.75 |
| Total Liabilities |
510,089,432.63 |
| Paid-In Capital(Or Share Stock) |
901,623,135.00 |
| Capital Surplus |
1,127,835,418.19 |
| Surplus Reserve |
451,155,705.00 |
| LESS:Treasury Stock |
105,195,202.37 |
| Undistributed Profits |
5,895,667,984.02 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,271,218,158.07 |
| Owner's Equity（Stockholder's Equity） |
8,271,218,158.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,781,307,590.70 |
